Author name: TB Alliance

According to a new Global Alliance for TB Drugs Development report, the anti-tuberculosis drug market could reach $700 million by

Third-world health activists and the global pharmaceutical industry remain sharply at odds over the role of drug patents and price

NEW YORK (Reuters Health) – In a bid to promote industry interest in tuberculosis (TB) drugs, non-profit group the Global

In other health news: Trying to entice major drug companies into plunging into the tuberculosis market, the new Global Alliance

A nonprofit health group will issue a report Thursday designed to enlist drug makers in the fight against tuberculosis, a

Les maladies infectieuses constituent aujourd’hui la principale cause de mortalité dans le monde avec 17 millions de victimes chaque année.

Drug makers and wealthy governments aren’t doing enough to develop new medicines to combat several serious diseases that are prevalent

Maria Freire, director of NIH’s Office of Technology Transfer, has been chosen as the new CEO of the Global Alliance

The first Gordon Research Conference on tuberculosis drug development was held at Colby-Sawyer College in New London, New Hampshire on